Does Epiphora Cause Meibomian Gland Loss and Dry Eye?

Purpose To investigate the effects of epiphora due to primary acquired nasolacrimal duct obstruction (PANDO) and external dacryocystorhinostomy (DCR) for its treatment on meibomian glands and tear film parameters. Methods External DCR for unilateral PANDO in the Department of Ophthalmology, Faculty...

Full description

Bibliographic Details
Main Authors: Berna Akova, Sertaç Argun Kıvanç, Kübra Tinç
Format: Article
Language:English
Published: Clinical and Experimental Ocular Trauma and Infection 2024-01-01
Series:Clinical and Experimental Ocular Trauma and Infection
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/3619776
_version_ 1797356304610623488
author Berna Akova
Sertaç Argun Kıvanç
Kübra Tinç
author_facet Berna Akova
Sertaç Argun Kıvanç
Kübra Tinç
author_sort Berna Akova
collection DOAJ
description Purpose To investigate the effects of epiphora due to primary acquired nasolacrimal duct obstruction (PANDO) and external dacryocystorhinostomy (DCR) for its treatment on meibomian glands and tear film parameters. Methods External DCR for unilateral PANDO in the Department of Ophthalmology, Faculty of Medicine, Bursa Uludag University between January 2018-June 2019 were reviewed. The tear film parameters and meibography measurement recorded at the preoperative and follow-up examinations were examined on both the obstructed side and the patent side. SPSS 23 was used for statistical analyzed. Results There was a significant difference between Schirmer-1 score before external DCR (13,1±5,0; 6,3±5,0; p=0,01) and this difference disappeared after surgery (12,0±7,3; 7,7±5,0; p=0,06). Postoperative increase in non-invasive average break-up time (niAVG-BUT) on operated side was statistically significant (10,5±4,6; 12,0±5,3; p=0,033). When the healthy and operated sides were compared with each other, no significant difference was observed in niAVG-BUT before and after surgery (p=0,907, p=0,614). Mean meibomian gland losses were decreased in both operated and patent sides postoperatively and these values were statistically significant (33,0±8,2; 27,1±6,8; p<0,001, 37,3±10,4; 31,4±9,6; p=0,01). Conclusion Patients with unilateral nasolacrimal duct obstruction (NLDO) had loss of meibomian gland in both NLDO side and patent side. This loss was found to be significantly reduced on both obstructed and patent sides after successful surgical removal of the epiphora.
first_indexed 2024-03-08T14:24:41Z
format Article
id doaj.art-ea67d45546574ce3a93f76152808bc33
institution Directory Open Access Journal
issn 2667-8462
language English
last_indexed 2024-03-08T14:24:41Z
publishDate 2024-01-01
publisher Clinical and Experimental Ocular Trauma and Infection
record_format Article
series Clinical and Experimental Ocular Trauma and Infection
spelling doaj.art-ea67d45546574ce3a93f76152808bc332024-01-13T09:32:34ZengClinical and Experimental Ocular Trauma and InfectionClinical and Experimental Ocular Trauma and Infection2667-84622024-01-015116251411Does Epiphora Cause Meibomian Gland Loss and Dry Eye?Berna Akova0Sertaç Argun Kıvanç1Kübra Tinç2BURSA ULUDAG UNIVERSITYBURSA ULUDAG UNIVERSITYUNIVERSITY OF HEALTH SCIENCES, ERZURUM REGION HEALTH RESEARCH CENTERPurpose To investigate the effects of epiphora due to primary acquired nasolacrimal duct obstruction (PANDO) and external dacryocystorhinostomy (DCR) for its treatment on meibomian glands and tear film parameters. Methods External DCR for unilateral PANDO in the Department of Ophthalmology, Faculty of Medicine, Bursa Uludag University between January 2018-June 2019 were reviewed. The tear film parameters and meibography measurement recorded at the preoperative and follow-up examinations were examined on both the obstructed side and the patent side. SPSS 23 was used for statistical analyzed. Results There was a significant difference between Schirmer-1 score before external DCR (13,1±5,0; 6,3±5,0; p=0,01) and this difference disappeared after surgery (12,0±7,3; 7,7±5,0; p=0,06). Postoperative increase in non-invasive average break-up time (niAVG-BUT) on operated side was statistically significant (10,5±4,6; 12,0±5,3; p=0,033). When the healthy and operated sides were compared with each other, no significant difference was observed in niAVG-BUT before and after surgery (p=0,907, p=0,614). Mean meibomian gland losses were decreased in both operated and patent sides postoperatively and these values were statistically significant (33,0±8,2; 27,1±6,8; p<0,001, 37,3±10,4; 31,4±9,6; p=0,01). Conclusion Patients with unilateral nasolacrimal duct obstruction (NLDO) had loss of meibomian gland in both NLDO side and patent side. This loss was found to be significantly reduced on both obstructed and patent sides after successful surgical removal of the epiphora.https://dergipark.org.tr/tr/download/article-file/3619776epiphorameibomian glanddacryocystorhinostomydry eyemeibographyophthalmology
spellingShingle Berna Akova
Sertaç Argun Kıvanç
Kübra Tinç
Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
Clinical and Experimental Ocular Trauma and Infection
epiphora
meibomian gland
dacryocystorhinostomy
dry eye
meibography
ophthalmology
title Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
title_full Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
title_fullStr Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
title_full_unstemmed Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
title_short Does Epiphora Cause Meibomian Gland Loss and Dry Eye?
title_sort does epiphora cause meibomian gland loss and dry eye
topic epiphora
meibomian gland
dacryocystorhinostomy
dry eye
meibography
ophthalmology
url https://dergipark.org.tr/tr/download/article-file/3619776
work_keys_str_mv AT bernaakova doesepiphoracausemeibomianglandlossanddryeye
AT sertacargunkıvanc doesepiphoracausemeibomianglandlossanddryeye
AT kubratinc doesepiphoracausemeibomianglandlossanddryeye